NYLI Cushing MLP Premier Fund (I shares) returned +5.38% for the quarter, delivering solid absolute performance while ...

Archer-Daniels-Midland navigates challenges like weak soybean margins and trade tensions with cost cuts and diversification.

Kura Oncology's ziftomenib shows promise in AML treatment, with FDA Priority Review ahead. Read here for an analysis of KURA ...

Overweight position in the CMBS sector, particularly the AAA Agency subcomponent, was accretive to the NYLI Short Term Bond ...

Meta's AI investments, open-source strategy, and Zuckerberg's bold vision position it as a leader against OpenAI & Google.

Thrivent Mid Cap Value Fund underperformed its benchmark, Russell Midcap Value Index, during the quarter driven by negative stock selection. Performance was negative in 6 out of 11 sectors led by ...